Daniel C. Ihde, MD
Lung cancer is the second most common cancer and the most common fatal cancer in the United States (2). Three fourths of these malignancies are pathologically diagnosed as squamous, large cell, or adenocarcinoma. These histologic subtypes are often viewed as a single entity, non-small cell lung cancer, because they exhibit similar biologic behavior. In contrast to small-cell carcinoma, they often present as sufficiently localized neoplasms that may be approached surgically with curative intent but are relatively unresponsive to cytotoxic chemotherapy.
Between one fourth and one third of patients with non-small cell lung cancer do not have clinically detectable distant metastatic
Ihde DC. Chemotherapy Combined with Chest Irradiation for Locally Advanced Non-Small Cell Lung Cancer: The End of the Beginning?. Ann Intern Med. ;115:737–739. doi: 10.7326/0003-4819-115-9-737
Download citation file:
Published: Ann Intern Med. 1991;115(9):737-739.
Hematology/Oncology, Lung Cancer, Pulmonary/Critical Care.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use